Effects of acamprosate and scopolamine on the working memory of rats in a three-panel runway task

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 12, Issue 3, 2001, Pages 197-216

  Okulicz Kozaryn, Irena ^a   Midolajczak, Przemyslaw ^a   Szczawinska, Krystyna ^a   Kaminska, Ewa ^a   Kus, Krzysztof ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

calcium acetyl homotaurinate; cholinergic receptors; rat

Indexed keywords

ACAMPROSATE; CHOLINERGIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; LATENT PERIOD; MALE; NONHUMAN; RAT; TASK PERFORMANCE; WORKING MEMORY;

ALCOHOL DETERRENTS; ANIMALS; DRUG INTERACTIONS; MALE; MEMORY; MUSCARINIC ANTAGONISTS; RATS; RATS, WISTAR; SCOPOLAMINE; TAURINE;

EID: 0035196037     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/JBCPP.2001.12.3.197     Document Type: Article

References (62)

1. Hoes, MJ. Relapse prevention in alcoholics. A review of acamprosate versus naltrexone. Clin Drug Invest 1999; 17: 211–216.
2. Garbutt, JC, West, SL, Carey, TS, Lohr, KN, Crews, FT. Pharmacological treatment of alcohol dependence: A review of the evidence. J Am Med Assoc 1999; 281: 1318–1325.
3. Johnson, BA, Ait-Daoud, N. Neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Psychopharmacology (Berl) 2000; 149: 327–344.
4. Spanagel, R, Zieglgansberger, W. Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 1997 18: 54–59.
5. Dahchour, A, De Witte, P. Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate. Prog Neurobiol 2000; 60: 343—362.
6. Durbin, P, Legrand, E, Daoust, M. Characterization of a central acamprosate binding site in rats. Alcohol Clin Exp Res 1996; 20: 7A.
7. Naassila, M, Hammoumi, S, Legrand, E, Durbin, P, Daoust, M. Mechanism of action of acamprosate. Part 1. Characterization of spermidine-sensitive acamprosate binding site in rat brain. Alcohol Clin Exp Res 1998; 22: 802–809.
8. A1 Qatari, M, Bouchenafa, O, Littleton, J. Mechanism of action of acamprosate. Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex. Alcohol Clin Exp Res 1998; 22: 810–814.
9. Popp, RL, Lovinger, DM. Interaction of acamprosate with ethanol and spermine on NMDA receptors in primary cultured neurons. Eur J Pharmacol 2000; 394: 221–231.
10. Izquierdo, I, Medina, JH. Correlation between the pharmacology of long-term potentiation and the pharmacology of memory. Neurobiol Learn Mem 1995; 63: 19–32.
11. Izquierdo, I, Medina, JH. Memory formation: The sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol Learn Mem 1997; 68: 285–316.
12. Bliss, TV, Collingridge, GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993; 361(6407): 31–39.
13. Parsons, OA. Neurocognitive deficits in alcoholics and social drinkers: A continuum? Alcohol Clin Exp Res 1998 22: 954–961.
14. Soyka, M, Aichmuller, C, Preuss, U, Moller, HJ. Effects of acamprosate on psychomotor performance and driving ability in abstinent alcoholics. Pharmacopsychiatry 1998; 31: 232–235.
15. Schneider, U, Wohlfarth, K, Schulze-Bonhage, A, Haacker, T, Muller-Vahl, KR, Zedler, M, et al. Effects of acamprosate on memory in healthy young subjects. J Stud Alcohol 1999; 60: 172–175.
16. Okulicz-Kozaryn, I, Mikolajczak, P, Kaminska, E, Szczawinska, K. Sedative effect of acamprosate and its influence on chosen memory tasks in two different aged rats. Eur Neuropsychopharmacol Suppl 3 1996; 6: 46, P-3–18.
17. Mikolajczak, P, Okulicz-Kozaryn, I, Kaminska, E, Rosol, A. Acamprosate effect of performance avoidance tasks in chronically ethanol-treated rats-A preliminary report. Eur J Pharmacol Sci 1994; 2: 168.
18. Mikolajczak, P, Okulicz-Kozaryn, I, Kaminska, E, Skolozdrzych, K. Multiple acamprosate administration effect on learning and memory in chronically ethanol-treated rats. Alcohol Alcohol 1997 Suppl; 32: 365, S59.
19. Ohno, M, Yamamoto, T, Watanabe, S. Effects of intrahippocampal injections of N-methyl-D-aspartate antagonists and scopolamine on working and reference memory assessed in rats by a the three-panel runway test. J Pharmacol Exp Ther 1992; 263: 943–950.
20. Ingram, DK, Shimada, A, Spangler, EL, Ikari, H, Hengemihle, J, Kuo, H, Greig, N. Cognitive enhancement. New strategies for stimulating cholinergic, glutamatergic, and nitric oxide systems. Ann NY Acad Sci 1996; 786: 348–361.
21. Ohno, M, Watanabe, S. Concurrent blockade of hippocampal metabo-tropic glutamate and N-methyl-D-aspartate receptors disrupts working memory in the rat. Neuroscience 1996; 70: 303–311.
22. Robinson, JK. Pharmacological models of amnesia: A reexamination of the effects of the cholinergic muscarinic receptor antagonist scopol-amine and the NMDA-receptor antagonist MK-801 on delayed nonmatching-to-position in rats. Psychobiology 1997; 25: 229–235.
23. Marino, MJ, Rouse, ST, Levey, AI, Potter, LT, Conn, PJ. Activation of the genetically defined ml muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells. Proc Natl Acad Sci USA 1998; 95: 11465–11470.
24. Furuya, Y, Yamamoto, T, Yatsugi, S, Ueki, S. A new method for studying working memory by using the three-panel runway apparatus in rats. Jpn J Pharmacol 1988; 46: 183–188.
25. Derrien, M, Dauge, V, Blommaert, A, Roques, BP. The selective CCK-B agonist, BC 264, impairs socially reinforced memory in the three-panel runway test in rats. Behav Brain Res 1994; 65: 139–146.
26. Beatty, WW, Bierley, RA. Scopolamine degrades spatial working memory but spares spatial reference memory: dissimilarity of anticholinergic effect and restriction of distal visual cues. Pharmacol Biochem Behav 1985; 23: 1–6.
27. Kishi, A, Ohno, M, Watanabe, S. Spermidine, a polyamine site agonist, attenuates working memory deficits caused by blockade of hippocampal muscarinic receptors and mGluRs in rats. Brain Res 1998; 793: 311–314.
28. Olton, S, Becker, JT, Handelmann, GE. Hippocampus, space and memory. Behav Brain Sci 1979; 793: 313–365.
29. Becker, JT, Morris, RG. Working memory(s). Brain Cogn 1999; 41: 1–8.
30. Zhou, H, Ge, X, Wang, L-Z, Ma, L, Pei, G. Attenuation of morphine tolerance and dependence in scopolamine-treated rats. Neuroreport 1999; 10: 2007–2010.
31. Mikolajczak, P, Okulicz-Kozaryn, I, Kaminska, E. Effects of acamprosate and baclofen on ethanol hypnotic action in chronically ethanol-treated rats. Alcohol Alcohol 1995; 30: 550, C10.13.
32. Mikolajczak, P, Okulicz-Kozaryn, I, Kaminska, E, Niedopad, L, Polanska, A. Effects of acamprosate and some polyamine site ligands of NMDA receptor on social memory in adult rats. Eur J Neurosci 2000; 12: Suppl 11: 101050.08.
33. Gewiss, M, Heidbreder, C, Opsomer, L, Durbin, P, De Witte, P. Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour. Alcohol Alcohol 1991; 26: 129–137.
34. Daoust, M, Legrand, E, Gewiss, M, Heidbreder, C, De Witte, P, Tran, G, Durbin, P. Acamprosate modulates synaptosomal GABA transmission in chronically alcoholized rats. Pharmacol Biochem Behav 1992; 41: 669–674.
35. Dahchour, A, De Witte, P. Acamprosate decreases the hypermotility during repeated ethanol withdrawal. Alcohol 1999; 18: 77–81.
36. Zeisse, HL, Kasparov, S, Caponga, M, Zieglgansberger, W. Acamprosate (calcium acetyl homotaurinate) decreases postsynaptic potentials in the rat neocortex: Possible involvement of excitatory amino acid receptors. Eur J Pharmacol 1993: 231: 47–52.
37. Madamba, SS, Schweitzer, P, Zieglgansberger, W, Siggins, GR. Acamprosate (calcium acetyl homotaurinate) enhances the N-methyl-D-aspartate component of excitatory neurotransmission in rat hippocampal CA1 neurons in vitro. Alcohol Clin Exp Res 1996; 20: 802–809.
38. 2+channels in cultured rat mesencephalic neurones. Nauyn-Schmiedeberg's Arch Pharmacol 2000; 362: 440–443.
39. Danysz, W, Wroblewski, JT. Amnestic properties of glutamate receptor antagonists. Neurosci Res Commun 1989; 5: 9–18.
40. Hlinak, Z, Krejci, I. Effect of excitatory amino acid antagonists on social recognition in male rats. Behav Pharmacol 1994; 5: 239–244.
41. Hlinak, Z, Krejci, I. Kynurenic acid and 5,7-dichlorokynurenic acids improve social and object recognition in male rats. Psychopharmacology (Berl). 1995;120:463–469.
42. Quevedo, J, Vianna, M, Zanatta, MS, Roesler, R, Izquierdo, I, Jerusalinsky, D, Quillfeldt, JA. Involvement of mechanisms dependent on NMDA receptors, nitric oxide and protein kinase A in the hippocampus but not in the caudate nucleus in memory. Behav Pharmacol 1997; 8: 713–717.
43. Carey, RJ, Dai, H, Gui, J. Effects of dizocilpine (MK-801) on motor activity and memory. Psychopharmacology (Berl). 1998; 137: 241–246.
44. Doyle, KM, Feerick, S, Kirkby, DL, Eddleston, A, Higgins, GA. Comparison of various N-methyl-D-aspartate receptor antagonists in a model of short-term memory and on overt behaviour. Behav Pharmacol 1998; 9: 671–681.
45. Aura, J, Riekkinen, P Jr. Blockade of NMDA receptors located at the dorsomedial prefrontal cortex impairs spatial working memory in rats. Neuroreport. 1999; 10:243–248.
46. Presburger, G, Robinson, JK. Spatial signal detection in rats is differentially disrupted by delta-9-tetrahydrocannabinol, scopolamine, and MK-801. Behav Brain Res 1999; 99: 27–34.
47. Spanagel, R, Zieglgansberger, W, Hundt, W. Acamprosate and alcohol: III: Effects on alcohol discrimination in the rat. Eur J Pharmacol 1996; 305: 51–56.
48. Williams, K, Romano, C, Dichter, MA, Molinoff, PB. Modulation of the NMDA receptor by polyamines. Life Sci 1991; 48: 469–498.
49. Johnson, TD. Modulation of channel function by polyamines. Trends Pharmacol Sci 1996; 17: 22–27.
50. Yamamura, T, Shimoui, K. Subunit- and site-specific pharmacology of the NMDA receptor channel. Prog Neurobiol 1999; 59: 279–298.
51. London, ED, Mukhin, A. Polyamines as endogenous modulators of the N-methyl-D-aspartate receptor. Ann NY Acad Sci 1995; 757: 430–436.
52. Rubin, MA, Boemo, RL, Jurach, A, Rojas, DB, Zanolla, GR, Obregon, AD, et al. Intrahippocampal spermidine administration improves inhibitory avoidance performance in rats. Behav Pharmacol 2000; 11: 57–61.
53. Meyer, RC, Knox, J, Purwin, DA, Spangler, EL, Ingram, DK. Combined stimulation of the glycine and polyamine sites of the NMDA receptor attenuates NMDA blockade-induced learning deficits of rats in a 14-unit T-maze. Psychopharmacology (Berl) 1998; 135: 290–295.
54. Steckler, T, Sahgal, A, Aggleton, JP, Drinkenburg, WH. Recognition memory in rats—III. Neurochemical substrates. Prog Neurobiol 1998; 54: 333–348.
55. Wrenn, CC, Lappi, DA, Wiley, RG. Threshold relationship between lesion extent of the cholinergic basal forebrain in the rat and working memory impairment in the radial maze. Brain Res 1999; 847: 284–298.
56. Everitt, BJ, Robbins, TW. Central cholinergic systems and cognition. Annu Rev Psychol 1997; 48: 649–684.
57. Sarter, M, Bruno, JP. Cognitive functions of cortical acetylcholine: Toward a unifying hypothesis. Brain Res Rev 1997; 23: 28–46.
58. Dukoff, R, Wilkinson, CW, Lasser, R, Friz, J, Conway, A, Bahro, M, et al. Physostigmine challenge before and after chronic cholinergic blockade in elderly volunteers. Biol Psychiatry 1999; 46: 189–195.
59. Markram, H, Segal, M. Long-lasting facilitation of excitatory postsynaptic potentials in the rat hippocampus by acetylcholine. J Physiol 1990; 427: 381–393.
60. Matsuoka, N, Aigner, TG. Cholinergic-glutamanergic interactions in visual recognition memory of rhesus monkeys. Neuroreport 1996; 7: 565–569.
61. Fishkin, RJ, Ince, ES, Carlezon, WA Jr, Dunn, RW. D-cycloserine attenuates scopolamine-induced learning and memory deficits in rats. Behav Neural Biol 1993; 59: 150–157.
62. Schneider, U, Wohlfahrt, K, Schulze-Bonhage, A, Haacker, T, Caspary, A, Zedler, M, Emrich, HM,. Lack of psychotomimetic or impairing effects on psychomotor performance of acamprosate. Pharmacopsychiatry. 1998; 31: 110–113.